Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapse
oleh: Katja Sockel, Martin Wermke, Jörgen Radke, Alexander Kiani, Markus Schaich, Martin Bornhäuser, Gerhard Ehninger, Christian Thiede, Uwe Platzbecker
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2011-10-01 |
Deskripsi
No description available for this item.